Moore Matthew Richard
Insider CIK 1840191 · ARQT See Remarks · VTYX Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VTYX Ventyx Biosciences, Inc. | D To issuer deriv | 2026-03-04 | 2026-03-04 | 145,000 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | D To issuer deriv | 2026-03-04 | 2026-03-04 | 320,000 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 145,000 | — | $0 | 145,000 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2024-05-16 | 2024-05-17 | 320,000 | — | $0 | 320,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2024-05-02 | 2024-05-03 | 4,681 | $8.74 | $40.9K | 145,505 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-05-01 | 2024-05-03 | 4,166 | — | $0 | 150,186 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2024-03-04 | 2024-03-06 | 3,468 | $11.12 | $38.6K | 146,020 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | D To issuer deriv | 2024-02-13 | 2024-02-15 | 12,500 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | D To issuer deriv | 2024-02-13 | 2024-02-15 | 39,500 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | D To issuer deriv | 2024-02-13 | 2024-02-15 | 35,300 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | D To issuer deriv | 2024-02-13 | 2024-02-15 | 80,000 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | D To issuer deriv | 2024-02-13 | 2024-02-15 | 80,000 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-02-13 | 2024-02-15 | 19,750 | — | $0 | 145,322 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-02-13 | 2024-02-15 | 17,650 | — | $0 | 125,572 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-02-13 | 2024-02-15 | 26,666 | — | $0 | 81,256 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-02-13 | 2024-02-15 | 4,166 | — | $0 | 149,488 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-02-13 | 2024-02-15 | 26,666 | — | $0 | 107,922 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2024-01-12 | 2024-01-17 | 126,000 | — | $0 | 126,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-01-12 | 2024-01-17 | 28,000 | — | $0 | 54,590 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2023-08-29 | 2023-09-12 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2023-03-02 | 2023-03-06 | 39,500 | — | $0 | 39,500 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2023-03-02 | 2023-03-06 | 1,589 | $15.82 | $25.1K | 11,711 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2023-03-02 | 2023-03-06 | 21 | $16.52 | $347 | 11,690 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2023-03-02 | 2023-03-06 | 14,900 | — | $0 | 26,590 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2022-03-03 | 2022-03-07 | 35,300 | — | $0 | 35,300 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2022-03-03 | 2022-03-07 | 13,300 | — | $0 | 13,300 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2021-01-19 | 2021-01-21 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2021-01-19 | 2021-01-21 | 80,000 | — | $0 | 80,000 | SEC↗ |